Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WHO and World Bank to examine effect of global initiatives

This article was originally published in Scrip

Executive Summary

The World Health Organization (WHO) and the World Bank will jointly examine the effect of global disease-specific health initiatives in low- and middle-income countries. The move is after critics argued that they (the organizations?) were eroding already weak health systems. The two organisations will work with country officials, academic and research institutions, global health initiatives and civil society organisations to address whether global health initiatives are weakening systems or if health systems are preventing the progress of the initiatives and undermining investments. The collaboration will examine and combine the strengths of different approaches of initiatives to achieve better results from funding and improve health. There are currently more than 80 global health initiatives, including the GAVI Alliance, PEPFAR and the Global Fund.

Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC003315

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel